SCHEMBL6975576

SCHEMBL6975576

N[C@H]1CCN(Cc2cccnc2)C1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.59
CHRNA4 P43681 1/20 0.59
ALDH1A1 P00352 2/20 0.51
MAPT P10636 1/20 0.51
HTT P42858 1/20 0.51
KDM4E B2RXH2 2/20 0.50
TRPV6 Q9H1D0 2/20 0.49
SIGMAR1 Q99720 1/20 0.48
CHRNA7 P36544 1/20 0.48
TDP1 Q9NUW8 1/20 0.47
MAPK1 P28482 1/20 0.46
KMT2A Q03164 2/20 0.46
SLC18A3 Q16572 2/20 0.46
CHRM2 P08172 1/20 0.46
CHRM3 P20309 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2037248 1.00 CHRNB2 (0.59) CHRNB2CHRNA4ALDH1A1MAPTHTT
Hydrochloric Acid SCHEMBL8052496 0.98 CHRNB2 (0.58) CHRNB2CHRNA4ALDH1A1MAPTHTT
SCHEMBL27196354 0.91 CHRNB2 (0.65) CHRNB2CHRNA4ALDH1A1MAPTHTT
SCHEMBL13850152 0.91 CHRNB2 (0.65) CHRNB2CHRNA4ALDH1A1MAPTHTT
SCHEMBL5015324 0.91 CHRNB2 (0.68) CHRNB2CHRNA4ALDH1A1KDM4ETRPV6
Hydrochloric Acid SCHEMBL61401 0.89 CHRNB2 (0.66) CHRNB2CHRNA4ALDH1A1KDM4ETRPV6
SCHEMBL938061 0.86 CHRNB2 (0.61) CHRNB2CHRNA4ALDH1A1MAPTHTT
SCHEMBL6399377 0.82 CHRNB2 (0.59) CHRNB2CHRNA4ALDH1A1MAPTHTT
SCHEMBL6398126 0.82 CHRNB2 (0.59) CHRNB2CHRNA4ALDH1A1MAPTHTT
SCHEMBL14197746 0.82 CHRNB2 (0.59) CHRNB2CHRNA4ALDH1A1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed
EP-1100797-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES Pfizer Limited (GB) 2001-05-23 EP disclosed
WO-2000005232-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LIMITED (GB) 2000-02-03 WO disclosed